Fludiazepam is a potent benzodiazepine and 2-fluoro derivative of diazepam, originally developed by Hoffman-La Roche in the 1960s. Fludiazepam is marketed in Japan and Taiwan under the brand name Erispan. Fludiazepam exerts its pharmacological properties via enhancement of GABAergic inhibition. Fludiazepam has 4 times more binding affinity for benzodiazepine receptors than diazepam. Fludiazepam possesses anxiolytic, anticonvulsant, sedative, hypnotic and skeletal muscle relaxant properties.

Fludiazepam:
https://drugs.ncats.io/drug/7F64A2K16Z

Fludiazepam is only found in individuals that have used or taken this drug. It is a drug which is a benzodiazepine derivative. It possesses anxiolytic, anticonvulsant, sedative and skeletal muscle relaxant properties. It is a scheduled drug in the U.S., but is approved for use in Japan. Fludiazepam has similar action to diazepam, but binds with four times more affinity to benzodiazepine receptors than diazepam. This compound belongs to the class of organic compounds known as 1,4-benzodiazepines.

Excerpt from hmdb.ca:
http://www.hmdb.ca/metabolites/HMDB0015513

Fludiazepam is an anxiolytic drug (alleviate anxiety, tension, and anxiety disorders, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions).

Excerpt from European Bioinformatics Institute:
https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:31618

Fludiazepam Safety Data Sheet (PDF 5 pages):
https://www.caymanchem.com/msdss/22424m.pdf

Fludiazepam is used for the short-term treatment of anxiety disorders. It's a potent derivative of diazepam (benzodiazepine) originally developed in the 1960s. It is marketed in Japan and Taiwan as Erispan.